Bob Burgin has 20 years of executive management experience with venture capital backed companies. Most recently he served as Chairman/CEO of StrionAir, Inc., an air filtration bio-terrorist defense company that he helped launch in 2001 and which he continues to serve as a Director. Mr. Burgin also served as CEO of Finali Corporation, a BVIII portfolio company sold to Convergys Corporation (NYSE: CVG) in 2004. He previously served on the executive team of TheraTx, Inc. which was ranked the 2nd fastest growing small public company in America by Inc. Magazine, where he helped to close a $112 million secondary public offering. Mr. Burgin holds a Business and Economics degree from Trinity University.